Annual EBIT
-$11.73 M
+$10.03 M+46.09%
01 December 2023
Summary:
Addex Therapeutics Ltd annual earnings before interest & taxes is currently -$11.73 million, with the most recent change of +$10.03 million (+46.09%) on 01 December 2023. During the last 3 years, it has risen by +$1.91 million (+14.00%). ADXN annual EBIT is now -156.15% below its all-time high of $22.76 million.ADXN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$1.61 M
-$769.30 K-91.53%
01 June 2024
Summary:
Addex Therapeutics Ltd quarterly earnings before interest & taxes is currently -$1.61 million, with the most recent change of -$769.30 thousand (-91.53%) on 01 June 2024. Over the past year, it has increased by +$1.35 million (+45.60%). ADXN quarterly EBIT is now -303.56% below its all-time high of -$398.90 thousand, reached on 31 March 2023.ADXN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$8.62 M
-$1.03 M-13.57%
01 June 2024
Summary:
Addex Therapeutics Ltd TTM earnings before interest & taxes is currently -$8.62 million, with the most recent change of -$1.03 million (-13.57%) on 01 June 2024. Over the past year, it has dropped by -$899.20 thousand (-11.64%). ADXN TTM EBIT is now -186.41% below its all-time high of -$3.01 million, reached on 31 March 2019.ADXN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADXN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.1% | +45.6% | -11.6% |
| 3 y3 years | +14.0% | +58.8% | +39.6% |
| 5 y5 years | -659.8% | +55.4% | +22.1% |
ADXN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +46.1% | -303.6% | +78.5% | -20.6% | +62.1% |
| 5 y | 5 years | -659.8% | +46.1% | -303.6% | +78.5% | -20.6% | +62.1% |
| alltime | all time | -156.2% | +70.3% | -303.6% | +78.5% | -186.4% | +62.1% |
Addex Therapeutics Ltd EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$1.61 M(+91.5%) | -$8.62 M(+13.6%) |
| Mar 2024 | - | -$840.50 K(-73.8%) | -$7.59 M(+6.2%) |
| Dec 2023 | -$11.73 M(-46.1%) | -$3.21 M(+8.6%) | -$7.15 M(-7.4%) |
| Sept 2023 | - | -$2.96 M(+410.8%) | -$7.72 M(-14.3%) |
| June 2023 | - | -$579.40 K(+45.2%) | -$9.01 M(-43.3%) |
| Mar 2023 | - | -$398.90 K(-89.5%) | -$15.90 M(-27.0%) |
| Dec 2022 | -$21.76 M(+30.1%) | -$3.79 M(-10.8%) | -$21.78 M(-4.4%) |
| Sept 2022 | - | -$4.25 M(-43.2%) | -$22.79 M(+1.5%) |
| June 2022 | - | -$7.47 M(+18.9%) | -$22.45 M(+11.7%) |
| Mar 2022 | - | -$6.28 M(+31.1%) | -$20.10 M(+20.3%) |
| Dec 2021 | -$16.73 M(+22.6%) | -$4.79 M(+22.5%) | -$16.72 M(+17.2%) |
| Sept 2021 | - | -$3.91 M(-23.7%) | -$14.27 M(+2.3%) |
| June 2021 | - | -$5.12 M(+77.0%) | -$13.95 M(+15.9%) |
| Mar 2021 | - | -$2.90 M(+23.7%) | -$12.04 M(-11.1%) |
| Dec 2020 | -$13.64 M | -$2.34 M(-34.8%) | -$13.53 M(-8.9%) |
| Sept 2020 | - | -$3.59 M(+11.7%) | -$14.86 M(-0.2%) |
| June 2020 | - | -$3.21 M(-26.9%) | -$14.88 M(-7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$4.39 M(+19.9%) | -$16.12 M(+9.4%) |
| Dec 2019 | -$14.75 M(+855.1%) | -$3.66 M(+1.4%) | -$14.74 M(+33.1%) |
| Sept 2019 | - | -$3.61 M(-18.9%) | -$11.08 M(+48.4%) |
| June 2019 | - | -$4.45 M(+47.9%) | -$7.47 M(+147.9%) |
| Mar 2019 | - | -$3.01 M | -$3.01 M |
| Dec 2018 | -$1.54 M(-53.6%) | - | - |
| Dec 2017 | -$3.33 M(+4.8%) | - | - |
| Dec 2016 | -$3.18 M(-23.8%) | - | - |
| Dec 2015 | -$4.17 M(+114.5%) | - | - |
| Dec 2014 | -$1.94 M(-87.5%) | - | - |
| Dec 2013 | -$15.60 M(-45.0%) | - | - |
| Dec 2012 | -$28.37 M(-19.1%) | - | - |
| Dec 2011 | -$35.06 M(+9.6%) | - | - |
| Dec 2010 | -$32.00 M(-18.9%) | - | - |
| Dec 2009 | -$39.44 M(-288.8%) | - | - |
| Dec 2008 | $20.89 M(-171.5%) | - | - |
| Dec 2007 | -$29.24 M(+78.5%) | - | - |
| Dec 2006 | -$16.38 M | - | - |
FAQ
- What is Addex Therapeutics Ltd annual earnings before interest & taxes?
- What is the all time high annual EBIT for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual EBIT year-on-year change?
- What is Addex Therapeutics Ltd quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly EBIT year-on-year change?
- What is Addex Therapeutics Ltd TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd TTM EBIT year-on-year change?
What is Addex Therapeutics Ltd annual earnings before interest & taxes?
The current annual EBIT of ADXN is -$11.73 M
What is the all time high annual EBIT for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual earnings before interest & taxes is $22.76 M
What is Addex Therapeutics Ltd annual EBIT year-on-year change?
Over the past year, ADXN annual earnings before interest & taxes has changed by +$10.03 M (+46.09%)
What is Addex Therapeutics Ltd quarterly earnings before interest & taxes?
The current quarterly EBIT of ADXN is -$1.61 M
What is the all time high quarterly EBIT for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly earnings before interest & taxes is -$398.90 K
What is Addex Therapeutics Ltd quarterly EBIT year-on-year change?
Over the past year, ADXN quarterly earnings before interest & taxes has changed by +$1.35 M (+45.60%)
What is Addex Therapeutics Ltd TTM earnings before interest & taxes?
The current TTM EBIT of ADXN is -$8.62 M
What is the all time high TTM EBIT for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high TTM earnings before interest & taxes is -$3.01 M
What is Addex Therapeutics Ltd TTM EBIT year-on-year change?
Over the past year, ADXN TTM earnings before interest & taxes has changed by -$899.20 K (-11.64%)